Gene expression profiles in cells transformed by overexpression of the IGF-I receptor

Gary Loughran1, Merei Huigsloot, Patrick A Kiely

  • 1Cell Biology Laboratory, Department of Biochemistry, BioSciences Institute, National University of Ireland, Cork, Ireland.

Oncogene
|June 9, 2005
PubMed

Insights

Researchers identified genes linked to insulin-like growth factor-I receptor (IGF-IR) in cellular transformation. These genes, including those for tumor growth and metastasis, may play a role in cancer progression.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The insulin-like growth factor-I receptor (IGF-IR) signaling pathway is implicated in cellular transformation and cancer progression.
  • Understanding the specific genes regulated by IGF-IR is crucial for identifying therapeutic targets.

Purpose of the Study:

  • To identify genes associated with IGF-IR-mediated cellular transformation.
  • To elucidate the role of specific genes in cancer growth, metastasis, and progression.

Main Methods:

  • Differential gene expression analysis between R- (IGF-IR knockout) and R+ (IGF-IR overexpressing) cells.
  • Confirmation of differential gene expression using Northern blot analysis.
  • Investigating the role of specific genes (e.g., mystique, lasp-1) in cancer cell lines (MCF-7) and their association with metastasis and invasion.

Main Results:

  • 45 genes showed higher expression in R+ cells, and 22 in R- cells.
  • Genes upregulated in R+ cells are associated with tumor growth, metastasis (e.g., betaigH3, mts1, mystique), cell division, signal transduction, and metabolism.
  • IGF-I induced expression of lasp-1 and mystique in MCF-7 cells; mystique overexpression promoted cell migration and invasion.
  • Lasp-1 expression was dependent on PI3-kinase signaling.

Conclusions:

  • The identified genes may mediate IGF-IR function in cancer progression.
  • Mystique is a potential mediator of metastasis and invasion, and its expression is linked to advanced prostate cancer.
  • Targeting IGF-IR-regulated genes could offer new strategies for cancer therapy.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...